Press & Media

Press Releases

FNIH Supports New NIH Study Seeking Biomarkers for Autism Spectrum Disorders

PDF release >>
The Foundation for the National Institutes of Health (FNIH) announced today a public-private collaboration with the National Institute of Mental Health (NIMH), a component of the National Institutes of Health, and the Simons Foundation Autism Research Initiative (SFARI), among others.

Russell W. Steenberg Elected to Foundation for the NIH Board of Directors

PDF release >>
The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has unanimously elected Russell W. Steenberg as a Director of the Foundation. His three-year term began immediately after the May 21 Board meeting.

Judy Lansing Kovler Elected to Foundation for the NIH Board of Directors

PDF release >>
The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has unanimously elected Judy Lansing Kovler, Ph.D., as a Director of the Foundation. Her three-year term began immediately after the May 21 Board meeting.

FNIH Pleased to Announce Workshop and Progress Update on Osteoarthritis Biomarkers Consortium Project

The Foundation for the National Institutes of Health (FNIH) is pleased to announce a workshop and progress update on the Osteoarthritis Biomarkers Consortium Project, which will be held immediately before the opening plenary session of the World Congress on Osteoarthritis in Seattle on April 30.

Foundation for the NIH to Support Worldwide Competition Focused on Improving the Accuracy of Lung Cancer Screenings

PDF release >>
The Foundation for the National Institutes of Health (FNIH) has been awarded a $2.4 million grant from the Laura and John Arnold Foundation (LJAF) to support a worldwide Coding for Cancer™ competition focused on improving the accuracy of lung cancer screenings.

Accelerating Medicines Partnership Announces Awards to Advance Research in Type 2 Diabetes

PDF release >>
The Foundation for the National Institutes of Health (FNIH) will award more than $3 and a half million to further the study of Type 2 Diabetes (T2D) as part of an unprecedented collaboration to develop new ways to diagnose and treat several pressing diseases.

Foundation for the NIH to Award Lurie Prize in Biomedical Sciences to Karl Deisseroth for Innovative Advances in Brain Research and Technology

Medal Recognizes the Development of Optogenetics and CLARITY, New Tools to Understand the Brain
PDF release >>

The Foundation for the National Institutes of Health (FNIH) has selected Karl Deisseroth, M.D., Ph.D., as the 2015 winner of the Lurie Prize in Biomedical Sciences for the development of optogenetics and CLARITY as tools to study the functions of cells, especially neurons. Dr. Deisseroth is being recognized for leading the development of optogenetics, a technology for controlling cells with light to determine function, as well as for CLARITY, a method for transforming intact organs into transparent polymer gels to allow visualization of biological structures with high resolution and detail. The Lurie Prize will be presented to Dr. Deisseroth on May 20, 2015 in Washington, D.C.

2015 FNIH Award Ceremony — May 20, 2015

On Wednesday, May 20, the Foundation for the National Institutes of Health (FNIH) will bring together leaders from biomedical science, the biotech and pharmaceutical industries, philanthropy and business, for the 2015 FNIH Award Ceremony and presentation of the Lurie Prize in Biomedical Sciences.

John & Marcia Goldman Foundation Donates to NIH Ebola Research

PDF release >>
Bethesda, MD.
, November 5, 2014 – In the first donation of its kind for the Foundation for the National Institutes of Health (FNIH), the John & Marcia Goldman Foundation has awarded $25,000 to support Ebola research in West Africa conducted by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

Lung-MAP Collaborative Clinical Trial Rapidly Expanding Across the Country

PDF release >>
The Lung-MAP trial, a multi-drug, multi-sub-study, biomarker-driven clinical trial for patients with advanced squamous cell lung cancer, that launched on June 16th 2014, today announced that it has expanded to an additional 169 locations throughout the United States. They join 85 locations that have been participating in the trial since the June launch. All locations can be found here: http://www.lung-map.org/locations